M. Schneider

Molecular Biology · Proceedings of the National Academy of Sciences of the United States of America · 2001–2010

A researcher in the Science corpus: 8 papers; trusts 4 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom M. Schneider trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Stefanie Dimmeler (in Molecular Biology)
  2. Paola Scaffidi (in Molecular Biology)
  3. Tom Misteli (in Molecular Biology)
  4. M. Bianchi (in Molecular Biology)

Who trusts M. Schneider

  1. Beth Levine (in Epidemiology)
  2. Guido Kroemer (in Epidemiology)
  3. I. Slaninová (in Epidemiology)
  4. Douglas R. Green (in Epidemiology)

Papers from M. Schneider's perspective

Ordered by how strongly the researchers M. Schneider trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Bone marrow cells regenerate infarcted myocardium (Nature)
  2. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. (The Lancet)
  3. Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure (Circulation)
  4. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function (Nature Medicine)
  5. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death (Nature)
  6. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. (Journal of Clinical Investigation)
  7. Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells (Circulation Research)
  8. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction (Proceedings of the National Academy of Sciences of the United States of America)
  9. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. (New England Journal of Medicine)
  10. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. (The Lancet)

Their papers